Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Pricing

High deductibles linked to lower Rx fills and cancer screenings

June 05, 2013

A study highlights medical service trends among patients with high-deductible plans but lacks insight on health impact and long-term costs.
 

Impact and importance of patient preference still TBD

May 29, 2013

JAMA's look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients.
 

Business briefs: AbbVie, AstraZeneca, Valeant, Merck, Novo Nordisk

May 28, 2013

AbbVie's Niaspan pricing gets a hard look; AstraZeneca buys up heart drug and company; Valeant expands eye care portfolio with B&L; Merck halts Parkinson's study; Novo explores liraglutide weight loss results.
 

Business Briefs: Docs question Gleevec price, Sanofi pill may delay MS onset

April 25, 2013

Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
 

Business briefs: Roche, Doximity and Bayer

April 23, 2013

Roche is shuttering a division and eliminating 170 jobs; Doximity has added another client; a cautiously-worded study indicates antidepressants may be linked to autism; and NICE has endorsed a new use for Bayer's Xarelto.
 

Studies show cost doesn't drive everything

April 22, 2013

Two studies show that it's not enough to focus on cost to alter healthcare.
 

Diagnosing pricing issues

April 10, 2013

CDC figures suggest patients are avoiding medications to save money, and show that out-of-pocket costs for US consumers are rising faster than those for consumers in many other countries
 

Success in emerging markets hinges on broad network

April 03, 2013

Execs told Booz & Co researchers that the relationships web in emerging markets needs to be deeper than one-on-one sales pitches.
 

For consumers, price isn't just a financial factor

February 06, 2013

A pair of studies suggests that consumers are hungry for information, and that price determines how patients perceive their risk for life-threatening conditions.
 

Santarus loads up on sales reps

January 29, 2013

The company is beefing up its marketing staff, using an iPad-equipped mix of in-house and contracted talent.
 

CBO: more scripts filled, less healthcare spending

December 04, 2012

The nonpartisan Congressional Budget Office is tallying medical savings differently, adding a new perspective to chatter about the financial implications of nonadherence and rising drug prices.
 

Company news: Roche, MRM, McKesson

September 20, 2012

Roche closes an R&D deal for NYC, MRM gets a new address and Arizona's AG is suing McKesson.
 

Congressmen make pricing plea to Gilead

August 16, 2012

Representatives from four states and the District of Columbia are asking Gilead to keep HIV drugs prices in check. The letter is a prelude to the FDA's August 27 review of the Quad pill.
 

Sanofi's talking allergy device an answer to Dey's EpiPen

August 14, 2012

The drugmaker's new auto-injecting epinephrine pen provides verbal cues during emergency allergic situations. It's the latest entry in a competitive market.
 

Company news: Corcept Therapeutics and Daiichi Sankyo

March 23, 2012

Corcept Therapeutics said its Cushing's syndrome drug will be launched three weeks earlier than expected.
 

In the long run, reforms mean less risk, lower rewards for pharmas

March 23, 2010

In broad strokes, the healthcare reform bill that the president signed this noon holds much the same promise for pharmas as an SSRI does for depression or bipolar patients: less high highs, less low lows, more certainty and stability.
 

Aging Committee raps pharma on brand drug price hikes

March 18, 2010

Armed with AARP and Kaiser Family research, members of the Senate Special Committee on Aging asked panelists why brand drug prices in the US continue to increase, while other countries pay half as much for the same products.
 

Sharp Rx price jumps way up, says GAO

January 12, 2010

A Government Accountability Office study found "extraordinary price increases" in 416 branded drug products (across 321 brands) between 2000 and 2008. That's about half of one percent of all branded drug products.
 
  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions